Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Recent studies suggest that popular weight loss drugs like Ozempic may offer surprising ... evidence linking weight loss to a decreased risk of cancer, this study suggests that the injections ...

So far, researchers have found that these meds may help reduce the risk of cardiovascular disease and colorectal cancer ... GLP-1 receptor agonists (like Ozempic) or a type of medicine known ...

Ozempic is a brand name of the drug semaglutide ... But studies published in 2024 showed there was little to no increased risk of contracting thyroid cancer while on these drugs.

Ozempic, Wegovy sales have soared in recent ... changes in vision, increased risk of thyroid cancer and others. “The receptors targeted by semaglutide are found in the brain but also in the ...

An Ozempic Expert Explains What You Need to Know ... finding a difference and others not finding a difference in cancer risk—seemed to come from the fact that some studies do what we did ...

Experts agreed that people on these weight loss drugs are unlikely to have an increased risk for thyroid cancer. A new study found that weight loss drugs like Ozempic and Wegovy may be ...

For years, people taking Ozempic or other drugs in the ... an advisory warning that alcohol raises the risk of at least seven types of cancer, and called for updated health warning labels on ...